Compare DELL & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DELL | MDT |
|---|---|---|
| Founded | 1984 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.6B | 125.3B |
| IPO Year | 1988 | N/A |
| Metric | DELL | MDT |
|---|---|---|
| Price | $129.51 | $96.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 18 |
| Target Price | ★ $164.60 | $108.44 |
| AVG Volume (30 Days) | 5.6M | ★ 5.8M |
| Earning Date | 11-25-2025 | 11-18-2025 |
| Dividend Yield | 1.62% | ★ 2.94% |
| EPS Growth | ★ 23.48 | 12.98 |
| EPS | ★ 7.50 | 3.69 |
| Revenue | ★ $104,090,000,000.00 | $34,758,000,000.00 |
| Revenue This Year | $19.23 | $8.61 |
| Revenue Next Year | $11.74 | $5.86 |
| P/E Ratio | ★ $17.24 | $26.16 |
| Revenue Growth | ★ 10.79 | 5.34 |
| 52 Week Low | $66.25 | $79.29 |
| 52 Week High | $168.08 | $106.33 |
| Indicator | DELL | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 38.22 |
| Support Level | $126.21 | $96.89 |
| Resistance Level | $128.85 | $99.26 |
| Average True Range (ATR) | 4.44 | 1.34 |
| MACD | -0.12 | -0.60 |
| Stochastic Oscillator | 36.19 | 6.58 |
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three market shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners, and also relies heavily on channel partners to fulfill its sales.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.